-+ 0.00%
-+ 0.00%
-+ 0.00%

Telix prices upsized US$600 million 1.5% convertible notes due 2031

PUBT·04/14/2026 22:42:44
Listen to the news
Telix prices upsized US$600 million 1.5% convertible notes due 2031
  • Telix priced US$600 million of 1.5% convertible notes due 2031, upsized from US$550 million on strong demand.
  • Initial conversion price set at US$13.85 per share, a 37.5% premium to reference price of A$14.22.
  • Telix plans to repurchase about A$637 million of its A$650 million convertible bonds due 2029, cancelling more than 85% of the outstanding notes.
  • Settlement for new notes offering, concurrent repurchase expected on April 22, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202604141841PR_NEWS_EURO_ND__EN34541) on April 14, 2026, and is solely responsible for the information contained therein.